Table of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
6. Global Diverticular Disease Market, by Type
6.1 Introduction
6.2 Diverticulosis
6.2.1 Market Estimates & Forecast, 2020-2027
6.3 Diverticulitis
6.3.1 Market Estimates & Forecast, 2020-2027
6.4 Diverticular Bleeding
6.4.1 Market Estimates & Forecast, 2020-2027
7. Global Diverticular Disease Market, by Diagnosis
7.1 Introduction
7.2 Barium X-ray
7.2.1 Market Estimates & Forecast, 2020-2027
7.3 Liver Function Test
7.3.1 Market Estimates & Forecast, 2020-2027
7.4 Stool Test
7.4.1 Market Estimates & Forecast, 2020-2027
7.5 CT Scan
7.5.1 Market Estimates & Forecast, 2020-2027
7.6 Blood Test
7.6.1 Market Estimates & Forecast, 2020-2027
7.7 Urine Test
7.7.1 Market Estimates & Forecast, 2020-2027
7.8 Ultrasound
7.8.1 Market Estimates & Forecast, 2020-2027
7.9 Others
7.9.1 Market Estimates & Forecast, 2020-2027
8. Global Diverticular Disease Market, by Treatment
8.1 Introduction
8.2 Medications
8.2.1 Antibiotics
8.2.2 Penicillin Antibiotic
8.2.3 Dietary Supplements
8.2.4 Market Estimates & Forecast, 2020-2027
8.3 Supportive Care
8.3.1 IV fluids
8.3.1.1 Market Estimates & Forecast, 2020-2027
8.4 Surgery
8.4.1 Market Estimates & Forecast, 2020-2027
9. Global Diverticular Disease Market, by End User
9.1 Introduction
9.2 Hospitals
9.2.1 Market Estimates & Forecast, 2020-2027
9.3 Specialty centers
9.3.1 Market Estimates & Forecast, 2020-2027
9.4 Research centers
9.4.1 Market Estimates & Forecast, 2020-2027
10 Global Diverticular Disease Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 U.K.
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
11 Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
12 Company Profiles
12.1 Abbott Laboratories
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financials
12.1.4 SWOT Analysis
12.2 Synergy Pharmaceuticals, Inc.
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Sucampo Pharmaceuticals, Inc.
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Valeant Pharmaceuticals International, Inc.
12.4.1 Company Overview
12.4.2 Product/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Ardelyx, Inc.
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.6 Astellas Pharma Inc.
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.7 Novartis AG
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Others
13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Pharmaceutical Industry
14 Appendix
LIST OF TABLES
Table 1 Diverticular Disease Industry Synopsis, 2020-2027
Table 2 Global Diverticular Disease Market Estimates and Forecast, 2020-2027, (USD Million)
Table 3 Global Diverticular Disease Market by Region, 2020-2027, (USD Million)
Table 5 Global Diverticular Disease Market by Treatment, 2020-2027, (USD Million)
Table 6 Global Diverticular Disease Market by Diagnosis, 2020-2027, (USD Million)
Table 7 Global Diverticular Disease Market by End Users, 2020-2027, (USD Million)
Table 8 North America Diverticular Disease Market by Treatment, 2020-2027, (USD Million)
Table 9 North America Diverticular Disease Market by Diagnosis, 2020-2027, (USD Million)
Table 10 North America Diverticular Disease Market by End Users, 2020-2027, (USD Million)
Table 11 US Diverticular Disease Market by Treatment, 2020-2027, (USD Million)
Table 12 US Diverticular Disease Market by Diagnosis, 2020-2027, (USD Million)
Table 13 US Diverticular Disease Market by End Users, 2020-2027, (USD Million)
Table 14 Canada Diverticular Disease Market by Treatment, 2020-2027, (USD Million)
Table 15 Canada Diverticular Disease Market by Diagnosis, 2020-2027, (USD Million)
Table 16 Canada Diverticular Disease Market by End Users, 2020-2027, (USD Million)
Table 17 South America Diverticular Disease Market by Treatment, 2020-2027, (USD Million)
Table 18 South America Diverticular Disease Market by Diagnosis, 2020-2027, (USD Million)
Table 19 South America Diverticular Disease Market by End Users, 2020-2027, (USD Million)
Table 20 Europe Diverticular Disease Market by Treatment, 2020-2027, (USD Million)
Table 21 Europe Diverticular Disease Market by Diagnosis, 2020-2027, (USD Million)
Table 22 Europe Diverticular Disease Market by End Users, 2020-2027, (USD Million)
Table 23 Western Europe Diverticular Disease Market by Treatment, 2020-2027, (USD Million)
Table 24 Western Europe Diverticular Disease Market by diagnosis, 2020-2027, (USD Million)
Table 25 Western Europe Diverticular Disease Market by End Users, 2020-2027, (USD Million)
Table 26 Eastern Europe Diverticular Disease Market by Treatment, 2020-2027, (USD Million)
Table 27 Eastern Europe Diverticular Disease Market by diagnosis, 2020-2027, (USD Million)
Table 28 Eastern Europe Diverticular Disease Market by End Users, 2020-2027, (USD Million)
Table 29 Asia Pacific Diverticular Disease Market by Treatment, 2020-2027, (USD Million)
Table 30 Asia Pacific Diverticular Disease Market by diagnosis, 2020-2027, (USD Million)
Table 31 Asia Pacific Diverticular Disease Market by End Users, 2020-2027, (USD Million)
Table 32 Middle East & Africa Diverticular Disease Market by Treatment, 2020-2027, (USD Million)
Table 33 Middle East & Africa Diverticular Disease Market by diagnoses, 2020-2027, (USD Million)
Table 34 Middle East & Africa Diverticular Disease Market by End Users, 2020-2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Diverticular Disease Market
Figure 3 Segmentation Market Dynamics for Diverticular Disease Market
Figure 4 Global Diverticular Disease Market Share, by Treatment 2020
Figure 5 Global Diverticular Disease Market Share, by Diagnosis 2020
Figure 6 Global Diverticular Disease Market Share, by End Users, 2020
Figure 7 Global Diverticular Disease Market Share, by Region, 2020
Figure 8 North America Diverticular Disease Market Share, by Country, 2020
Figure 9 Europe Diverticular Disease Market Share, by Country, 2020
Figure 10 Asia Pacific Diverticular Disease Market Share, by Country, 2020
Figure 11 Middle East & Africa Diverticular Disease Market Share, by Country, 2020
Figure 12 Global Diverticular Disease Market: Company Share Analysis, 2020 (%)
Figure 13 Abbott Laboratories: Key Financials
Figure 14 Abbott Laboratories: Segmental Revenue
Figure 16 Abbott Laboratories: Geographical Revenue
Figure 17 Synergy Pharmaceuticals, Inc.: Key Financials
Figure 18 Synergy Pharmaceuticals, Inc.: Segmental Revenue
Figure 19 Synergy Pharmaceuticals, Inc.: Geographical Revenue
Figure 20 Sucampo Pharmaceuticals, Inc.: Key Financials
Figure 21 Sucampo Pharmaceuticals, Inc.: Segmental Revenue
Figure 22 Sucampo Pharmaceuticals, Inc.: Geographical Revenue
Figure 23 Novartis AG: Key Financials
Figure 24 Novartis AG: Segmental Revenue
Figure 25 Novartis AG: Geographical Revenue
Figure 26 GlaxoSmithKline plc: Key Financials
Figure 27 GlaxoSmithKline plc: Segmental Revenue
Figure 28 GlaxoSmithKline plc. Geographical Revenue
Figure 29 Ardelyx, Inc.: Key Financials
Figure 30 Ardelyx, Inc.: Segmental Revenue
Figure 31 Ardelyx, Inc.: Geographical Revenue
Figure 32 Astellas Pharma Inc.: Key Financials
Figure 33 Astellas Pharma Inc.: Segmental Revenue
Figure 34 Astellas Pharma Inc.: Geographical Revenue
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
